ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 130 filers reported holding ACCELERON PHARMA INC in Q1 2016. The put-call ratio across all filers is 3.66 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,168,000 | -12.1% | 77,126 | -0.4% | 0.01% | -11.1% |
Q1 2019 | $3,606,000 | -0.3% | 77,426 | -6.8% | 0.01% | -10.0% |
Q4 2018 | $3,617,000 | -26.0% | 83,061 | -2.8% | 0.01% | -16.7% |
Q3 2018 | $4,891,000 | +24.8% | 85,461 | +5.8% | 0.01% | +20.0% |
Q2 2018 | $3,919,000 | -3.5% | 80,761 | -22.2% | 0.01% | -9.1% |
Q1 2018 | $4,061,000 | +0.3% | 103,861 | +8.9% | 0.01% | 0.0% |
Q4 2017 | $4,048,000 | +18.6% | 95,380 | +4.3% | 0.01% | +10.0% |
Q3 2017 | $3,414,000 | +52.1% | 91,480 | +23.8% | 0.01% | +42.9% |
Q2 2017 | $2,245,000 | +14.8% | 73,880 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $1,956,000 | -3.1% | 73,880 | -6.6% | 0.01% | -14.3% |
Q4 2016 | $2,018,000 | -29.5% | 79,080 | 0.0% | 0.01% | -30.0% |
Q3 2016 | $2,862,000 | +66.2% | 79,080 | +56.0% | 0.01% | +66.7% |
Q2 2016 | $1,722,000 | +28.8% | 50,680 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $1,337,000 | -45.1% | 50,680 | +1.4% | 0.01% | -44.4% |
Q4 2015 | $2,437,000 | +260.0% | 49,980 | +83.9% | 0.01% | +200.0% |
Q3 2015 | $677,000 | -33.1% | 27,180 | -15.0% | 0.00% | -25.0% |
Q2 2015 | $1,012,000 | -16.8% | 31,980 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,217,000 | – | 31,980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |